I am a
Home I AM A Search Login

Papers of the Week


2022


Health Psychol Res


10


5

Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia.

Authors

Han AH, Burroughs CR, Falgoust EP, Hasoon J, Hunt G, Kakazu J, Lee T, Kaye AM, Kaye AD, Ganti L
Health Psychol Res. 2022; 10(5):67898.
PMID: 36726477.

Abstract

The present investigation is a comprehensive review regarding the use of Suvorexant for insomnia treatment. It covers the background, pathophysiology, and significance of addressing insomnia, the pharmaceutical details of Suvorexant, and its safety, efficacy, and implications in treating insomnia. We further discuss Suvorexant's role in targeting insomnia with other comorbidities.